Loading…
No Chinese Communist SURPRISE Parties Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,649 other S bills in the 118th — cohort avg 33d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2024 · fourth_quarter · Medicare/Medicaid
Physician payment issues (MEI, E/M Budget Neutrality, APMs, MIPS) including SFC white paper: Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Prior authorization in Medicare Advantage; HR 1770/S. 2477 Equitable Community Access to Pharmacist Services Act HR 766/S 144 Preventive Health Savings Act HR 618/ S 131 Improving Access to Workers' Compensation for Injured Federal Workers Act of 2023. S.1512 - CONNECT for Health Act of 2021 Monitoring PBM legislation - S. 1967 and S. 1038 H.R. 4822, Health Care Price Transparency Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 3503, Value in Healthcare Act; H.R. 10545, American Relief Act, 2025
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Medicare/Medicaid
Physician payment issues (MEI, E/M Budget Neutrality, APMs, MIPS) including SFC white paper: Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Prior authorization in Medicare Advantage; HR 1770/S. 2477 Equitable Community Access to Pharmacist Services Act HR 766/S 144 Preventive Health Savings Act HR 618/ S 131 Improving Access to Workers' Compensation for Injured Federal Workers Act of 2023. S.1512 - CONNECT for Health Act of 2021 Monitoring PBM legislation - S. 1967 and S. 1038 H.R. 4822, Health Care Price Transparency Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3561, PATIENT Act of 2023; H.R. 3284, Providers and Payers COMPETE Act; S. 3503, Value in Healthcare Act;
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Trade (domestic/foreign)
Issues relating to trade with China; issues relating to RESTRICT Act (S. 686); issues relating to ANTI-SOCIAL CCP Act, (H.R. 1081); issues relating to China Trade Relations Act (S. 125); issues relating to De Minimis Reciprocity Act (S. 1969); issues relating to Import Security and Fairness Act (H.R. 4148); issues relating to STOP CCP Act (S. 852); issues relating to Chinese Military and Surveillance Company Sanctions Act (H.R. 760); issues relating to No Chinese Communist SURPRISE Parties Act (S. 144); issues relating to DENIAL Act (S. 2170); issues relating to China Financial Threat Mitigation Act (H.R. 1156); issues relating to Ending Chinas Developing Nation Status Act (S. 308); issues relating to Countering Economic Coercion Act (S. 295 / H.R. 1135); issues relating to Protecting American Farmland Act (H.R. 3996); issues relating to China Trade Relations Act (H.R. 638); issues relating to Ending Normal Trade Relations with China Act (S. 906); issues relating to domestic measures to promote innovation; and issues relating to diversifying and securing supply chains.
Client expense: $4,270,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Treasury, Dept of
2024 · second_quarter · Medicare/Medicaid
Physician payment issues (MEI, E/M Budget Neutrality, APMs, MIPS) Prior authorization in Medicare Advantage; HR 1770/S. 2477 Equitable Community Access to Pharmacist Services Act HR 766/S 144 Preventive Health Savings Act HR 618/ S 131 Improving Access to Workers' Compensation for Injured Federal Workers Act of 2023. S.1512 - CONNECT for Health Act of 2021 Monitoring PBM legislation - S. 1967 and S. 1038 H.R. 4822, Health Care Price Transparency Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3561, PATIENT Act of 2023;
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Trade (domestic/foreign)
Issues related to U.S.-China policy including customs duties, trade remedies, export controls, inbound investment and outbound investment reviews; issues relating to global infrastructure development; issues relating to domestic measures to promote innovation and secure supply chains; issues relating to the economic recommendations of the House Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party (House China Select Committee); issues relating to the U.S.-EU Trade and Technology Council; (H.R. 760); issues relating to China policy, including supply chains diversification; issues relating to the E-Commerce Moratorium; issues relating to Restricting the Emergence of Security Threats that Risk Information and Communications Technology (RESTRICT) Act (S. 686), Averting the National Threat of Internet Surveillance, Oppressive Censorship, Influence, and Algorithmic Learning by the Chinese Communist Party (ANTI-SOCIAL CCP) Act (H.R. 1081), China Trade Relations Act (S. 125), Ending Normal Trade Relations with China Act (S. 906), China Trade Relations Act (H.R. 638), De Minimis Reciprocity Act (S. 1969), Import Security and Fairness Act (H.R. 4148), Sanctioning Tyrannical and Oppressive People within the Chinese Communist Party (STOP CCP) Act (S. 852), Chinese Military and Surveillance Company Sanctions Act (H.R. 760), No Chinese Communist Subterfuge via Unregistered Regime Presence Rendered Invisible to Shareholders and Equivalent (SURPRISE) Parties Act (S. 144), Depriving Enemy Nations of Integral Authorizations and Licenses (DENIAL) Act (S. 2170), China Financial Threat Mitigation Act (H.R. 1156), Ending Chinas Developing Nation Status Act (S. 308), Countering Economic Coercion Act (S. 295/H.R. 1135), and Protecting American Farmland Act (H.R. 3996).
Client expense: $6,060,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2023 · fourth_quarter · Trade (domestic/foreign)
Issues relating to the RESTRICT Act (S. 686); issues relating to the ANTI-SOCIAL CCP Act (H.R. 1081); issues relating to the China Trade Relations Act (S. 125); issues relating to the Ending Normal Trade Relations with China Act (S. 906); issues relating to the China Trade Relations Act (H.R. 638); issues relating to the De Minimis Reciprocity Act (S. 1969); issues relating to the Import Security and Fairness Act (H.R. 4148); issues relating to the STOP CCP Act (S. 852); issues relating to the Chinese Military and Surveillance Company Sanctions Act (H.R. 760); issues relating to the No Chinese Communist SURPRISE Parties Act (S. 144); issues relating to the DENIAL Act (S. 2170); issues relating to the China Financial Threat Mitigation Act (H.R. 1156); issues relating to the Ending Chinas Developing Nation Status Act (S. 308); issues relating to the Countering Economic Coercion Act (S. 295 / H.R. 1135); issues relating to the National Defense Authorization Act (NDAA) for Fiscal Year 2024 (H.R. 2670 / S. 2226); issues relating to the Protecting American Farmland Act (H.R. 3996); issues related to the Chinese Military and Surveillance Company Sanctions Act (H.R. 760); issues related to the Preventing Adversaries from Developing Critical Capabilities Act (H.R. 6349); issues related to the economic recommendations of the House Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party (House China Select Committee) issues relating to China policy, including customs duties, trade remedies, export controls, inbound investment and outbound investment reviews; global infrastructure development; and domestic measures to promote innovation and secure supply chains.
Client expense: $6,250,000 · Firm income: Not reported
2023 · third_quarter · Trade (domestic/foreign)
Issues relating to the RESTRICT Act (S. 686); issues relating to the ANTI-SOCIAL CCP Act (H.R. 1081); issues relating to the China Trade Relations Act (S. 125); issues relating to the Ending Normal Trade Relations with China Act (S. 906); issues relating to the China Trade Relations Act (H.R. 638); issues relating to the De Minimis Reciprocity Act (S. 1969); issues relating to the Import Security and Fairness Act (H.R. 4148); issues relating to the STOP CCP Act (S. 852); issues relating to the Chinese Military and Surveillance Company Sanctions Act (H.R. 760); issues relating to the No Chinese Communist SURPRISE Parties Act (S. 144); issues relating to the DENIAL Act (S. 2170); issues relating to the China Financial Threat Mitigation Act (H.R. 1156); issues relating to the Ending Chinas Developing Nation Status Act (S. 308); issues relating to the Countering Economic Coercion Act (S. 295 / H.R. 1135); issues relating to the Protecting American Farmland Act (H.R. 3996); issues relating to the FY24 National Defense Authorization Act (S. 2226 / H.R. 2670). Issues relating to China policy, including: customs duties, trade remedies, export controls; inbound and outbound investment screening; sanctions; bilateral, plurilateral, and multilateral trade dialogues; global infrastructure development; and domestic measures to promote innovation and secure supply chains.
Client expense: $3,510,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)